Skip to main content

Table 1 Patient characteristics and histology of tumour samples

From: Undetectable thyroglobulin makes 123I whole-body scan and stimulated thyroglobulin obsolete in follow-up care of differentiated thyroid cancer: a retrospective study

Gender

- Male (n/total)

10/40 (25%)

- Female (n/total)

30/40 (75%)

Mean age (years)

45 ± 15

ATA 2015 risk stratification

- Low (n/total)

21/40 (52.5%)

- Intermediate (n/total)

15/40 (37.5%)

- High (n/total)

4/40 (10%)

Mean tumour size (cm ± SD)

2.4 ± 1.3

Lymph node dissection (n/total)

10/40 (25%)

T stage

- 1 (n/total)

15/40 (37.5%)

- 2 (n/total)

13/40 (32.5%)

- 3 (n/total)

12/40 (30%)

N stage

- 0 (n/total)

35/40 (87.5%)

- 1 (n/total)

5/40 (12.5%)

M stage

- 0 (n/total)

40/40 (100%)

- 1 (n/total)

0/40 (0%)

AJCC stagea (n/total)

- Stage 1 (n/total)

28/40 (70%)

- Stage 2 (n/total)

9/40 (22.5%)

- Stage 3 (n/total)

3/40 (7.5%)

- Stage 4 (n/total)

0/40 (0%)

Histology

- Papillary (n/total)

36/40 (90%)

- Follicular (n/total)

4/40 (10%)

Vascular invasion

- Yes (n/total)

14/40 (35%)

- No (n/total)

26/40 (65%)

Multifocal tumour

- Yes (n/total)

13/40 (32.5%)

- No (n/total)

27/40 (77.5%)

Microscopic positive margins

- Yes (n/total)

14/40 (35%)

- No (n/total)

26/40 (75%)

Post-ablation WBS

- Remnant (n/total)

33/40 (82.5%)

- Metastatic foci in the neck (n/total)

7/40 (17.5%)

- Distant foci (n/total)

0/40 (0%)

  1. aAJCC, American Joint Committee on Cancer